Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its fourth quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.07 for the period, compared to the consensus estimate of $0.06. The company issued revenue guidance of $60-$61 million, compared to the consensus revenue estimate of $60.33 million. Definitive Healthcare also updated its FY 2024 guidance to 0.340-0.350 EPS.
Definitive Healthcare Stock Up 0.2 %
DH traded up $0.01 during trading on Thursday, reaching $4.31. The stock had a trading volume of 543,715 shares, compared to its average volume of 748,693. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The stock’s 50 day moving average is $4.38 and its two-hundred day moving average is $5.04.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The firm had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The company’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the company earned $0.08 earnings per share. On average, analysts expect that Definitive Healthcare will post 0.07 EPS for the current fiscal year.
Analyst Ratings Changes
Read Our Latest Analysis on Definitive Healthcare
About Definitive Healthcare
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Articles
- Five stocks we like better than Definitive Healthcare
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Evaluate a Stock Before Buying
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.